• Preliminary evidence to Recommendations for the ongoing review of the PCV13 recommendation for adults ≥65 years old Cite CITE Title : Preliminary evidence to Recommendations for the ongoing review of the PCV13 recommendation for adults ≥65 years old Personal Author(s) : Matanock, Almea Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.) Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2018 October 24 : Atlanta, GA) Published Date : October 24, 2018 Series : ACIP meeting Pneumococcal Vaccines URL : https://stacks.cdc.gov/view/cdc/61453 Matanock, Almea (2018). Preliminary evidence to Recommendations for the ongoing review of the PCV13 recommendation for adults ≥65 years old. 201803(010206). Matanock, Almea "Preliminary evidence to Recommendations for the ongoing review of the PCV13 recommendation for adults ≥65 years old" 201803, no. 010206 (2018) Matanock, Almea "Preliminary evidence to Recommendations for the ongoing review of the PCV13 recommendation for adults ≥65 years old" vol. 201803, no. 010206, 2018 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 514.37 KB] Personal Author: Matanock, Almea October 24, 2018 | ACIP meeting Pneumococcal Vaccines No Description File Type: [PDF - 514.37 KB] File Type: [PDF - 514.37 KB] Estimating impact of 13-valent pneumococcal conjugate vaccine (PCV13) on pneumococcal pneumonia among U.S. adults Cite CITE Title : Estimating impact of 13-valent pneumococcal conjugate vaccine (PCV13) on pneumococcal pneumonia among U.S. adults Personal Author(s) : Gierke, Ryan Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.) Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2018 October 24 : Atlanta, GA) Published Date : October 24, 2018 Series : ACIP meeting Pneumococcal Vaccines URL : https://stacks.cdc.gov/view/cdc/61450 Gierke, Ryan (2018). Estimating impact of 13-valent pneumococcal conjugate vaccine (PCV13) on pneumococcal pneumonia among U.S. adults. 201803(010203). Gierke, Ryan "Estimating impact of 13-valent pneumococcal conjugate vaccine (PCV13) on pneumococcal pneumonia among U.S. adults" 201803, no. 010203 (2018) Gierke, Ryan "Estimating impact of 13-valent pneumococcal conjugate vaccine (PCV13) on pneumococcal pneumonia among U.S. adults" vol. 201803, no. 010203, 2018 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 682.34 KB] Personal Author: Gierke, Ryan October 24, 2018 | ACIP meeting Pneumococcal Vaccines No Description File Type: [PDF - 682.34 KB] File Type: [PDF - 682.34 KB] Economic analysis of sustaining the current recommendation for PCV13 use among adults 65 years or older in the context of continued indirect effects from the pediatric PCV13 program Cite CITE Title : Economic analysis of sustaining the current recommendation for PCV13 use among adults 65 years or older in the context of continued indirect effects from the pediatric PCV13 program Personal Author(s) : Stoecker, Charles Corporate Authors(s) : Tulane University. School of Public Health and Tropical Medicine. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2018 October 24 : Atlanta, GA) Published Date : October 24, 2018 Series : ACIP meeting Pneumococcal Vaccines URL : https://stacks.cdc.gov/view/cdc/61452 Stoecker, Charles (2018). Economic analysis of sustaining the current recommendation for PCV13 use among adults 65 years or older in the context of continued indirect effects from the pediatric PCV13 program. 201803(010205). Stoecker, Charles "Economic analysis of sustaining the current recommendation for PCV13 use among adults 65 years or older in the context of continued indirect effects from the pediatric PCV13 program" 201803, no. 010205 (2018) Stoecker, Charles "Economic analysis of sustaining the current recommendation for PCV13 use among adults 65 years or older in the context of continued indirect effects from the pediatric PCV13 program" vol. 201803, no. 010205, 2018 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 278.98 KB] Personal Author: Stoecker, Charles October 24, 2018 | ACIP meeting Pneumococcal Vaccines No Description File Type: [PDF - 278.98 KB] File Type: [PDF - 278.98 KB] Pneumococcal vaccines Cite CITE Title : Pneumococcal vaccines Personal Author(s) : Lee, Grace M. Corporate Authors(s) : United States. Advisory Committee on Immunization Practices. Pneumococcal Vaccines Work Group. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2018 October 24 : Atlanta, GA) Published Date : October 24, 2018 Series : ACIP meeting Pneumococcal Vaccines URL : https://stacks.cdc.gov/view/cdc/61448 Lee, Grace M. (2018). Pneumococcal vaccines. 201803(010201). Lee, Grace M. "Pneumococcal vaccines" 201803, no. 010201 (2018) Lee, Grace M. "Pneumococcal vaccines" vol. 201803, no. 010201, 2018 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 386.33 KB] Personal Author: Lee, Grace M. October 24, 2018 | ACIP meeting Pneumococcal Vaccines No Description File Type: [PDF - 386.33 KB] File Type: [PDF - 386.33 KB] Impact of PCV13 on invasive pneumococcal disease (IPD) burden and the serotype distribution in the U.S. Cite CITE Title : Impact of PCV13 on invasive pneumococcal disease (IPD) burden and the serotype distribution in the U.S. Personal Author(s) : Pilishvili, Tamara Corporate Authors(s) : United States. Advisory Committee on Immunization Practices. Pneumococcal Vaccines Work Group. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2018 October 24 : Atlanta, GA) Published Date : October 24, 2018 Series : ACIP meeting Pneumococcal Vaccines URL : https://stacks.cdc.gov/view/cdc/61449 Pilishvili, Tamara (2018). Impact of PCV13 on invasive pneumococcal disease (IPD) burden and the serotype distribution in the U.S.. 201803(010202). Pilishvili, Tamara "Impact of PCV13 on invasive pneumococcal disease (IPD) burden and the serotype distribution in the U.S." 201803, no. 010202 (2018) Pilishvili, Tamara "Impact of PCV13 on invasive pneumococcal disease (IPD) burden and the serotype distribution in the U.S." vol. 201803, no. 010202, 2018 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 278.07 KB] Personal Author: Pilishvili, Tamara October 24, 2018 | ACIP meeting Pneumococcal Vaccines No Description File Type: [PDF - 278.07 KB] File Type: [PDF - 278.07 KB]

More +